ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1111

The Effect of High Intensity Laser Therapy in the Management of Myofascial Pain Syndrome of the Trapezius: A Double Blind, Placebo-Controlled Study

Umit Dundar, Utku Turkmen, Hasan Toktas, Ozlem Solak and Alper Ulasli, Department of Physical Medicine and Rehabilitation, Afyon Kocatepe University, Faculty of Medicine, Afyonkarahisar, Turkey

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Disability, musculoskeletal disorders, pain, physical therapy and quality of life

  • Tweet
  • Email
  • Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes: Clinical Focus

Session Type: Abstract Submissions (ACR)

The effect of high intensity laser therapy in the management of myofascial pain syndrome of the trapezius: a double blind, placebo–controlled study

Abstract

Background/Purpose: Myofascial pain syndrome (MPS) of the trapezius muscle is one of the main causes of neck pain. In this randomized, double blinded study, we planned to evaluate the effects of high–intensity laser therapy (HILT) in female patients with chronic MPS of the trapezius muscle.

Methods : The female patients with the diagnosis of MPS of the trapezius muscle, were enrolled in the study and assigned to two groups. HILT group (group1) was treated with HILT and exercise. Sham therapy group (group2) received placebo HILT and exercise. The patients were assessed for pain, cervical active range of motion, disability and quality of life. Evaluations were performed before treatment (week 0) and after treatment (week 4 and week 12).

Results : Both groups showed significant improvement for all parameters  at week 4 and week 12. However, comparison of the percentage changes of parameters both at week 4 and week 12 relative to pretreatment values showed that improvement in pain scores, neck disability index and physical functioning, role limitations due to physical functioning, bodily pain, general health perceptions, social functioning and role limitations due to emotional problems subparts of SF-36 were better in HILT group.

Conclusion : As a result, it is concluded that HILT is an effective therapeutic method in the treatment of patients with chronic MPS of the trapezius muscle.

Key words: Myofascial pain syndrome, high–intensity laser therapy, exercise, pain, disability, quality of life.


Disclosure:

U. Dundar,
None;

U. Turkmen,
None;

H. Toktas,
None;

O. Solak,
None;

A. Ulasli,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-high-intensity-laser-therapy-in-the-management-of-myofascial-pain-syndrome-of-the-trapezius-a-double-blind-placebo-controlled-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology